/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments

Rx/Medicines

Topic

Latest Stories

CostcOzempic
4.3.24, 2:31 PM EDT on neoscope
Costco Now Offering Ozempic Prescriptions
Ozempic Baby
3.25.24, 6:30 PM EDT on neoscope
People Unexpectedly Getting Pregnant on Ozempic and Wegovy
Working It Out
3.21.24, 12:15 PM EDT on neoscope
Scientists Working on Pill You Can Take Instead of Exercising
Take a Shot
3.20.24, 9:00 AM EDT on neoscope
Oprah Questions Need For WeightWatchers Now That We Have Wegovy
Pill Pushers
3.18.24, 6:00 PM EDT on neoscope
Feds Investigating Whether Meta Profited From "Illicit" Drug Sales
Get It Covered
3.10.24, 12:00 PM EDT on neoscope
Wegovy Approved to Cut Heart Disease and Stroke Risk
Compounding Factors
3.2.24, 6:30 AM EST on neoscope
Woman Takes Grey Market Ozempic, Lands in Hospital
Market Sharing
2.22.24, 4:32 PM EST on neoscope
Indian Drugmakers Whipping Up Generic Versions of Wegovy
Crisis Aversion
2.1.24, 9:02 AM EST on neoscope
New Non-Opioid Drug Blocks Pain Signals Before They Can Reach Brain
Pill Mill
1.25.24, 11:18 AM EST on neoscope
Unregulated White House Pharmacy Gave Out Uppers and Downers to Senior Staff Under Trump
Low Risk
1.12.24, 9:08 AM EST on neoscope
The FDA Says Ozempic Probably Won't Make You Suicidal
Gains and Losses
1.4.24, 11:52 AM EST on neoscope
Semaglutide Patients Regained More Weight Than They’d Lost After Stopping Their Injections
  • Previous
  • 1
  • ...
  • 14
  • 15
  • 16
  • ...
  • 18
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.